Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+

  Pulmonary Hypertension

  Free Subscription


1 A A Pract
1 Am J Physiol Lung Cell Mol Physiol
1 Chest
1 Chin J Physiol
2 Circulation
1 Clin Respir J
1 Cochrane Database Syst Rev
1 Eur Heart J
1 Eur J Pharmacol
1 Int J Chron Obstruct Pulmon Dis
1 J Appl Physiol (1985)
1 J Cardiovasc Thorac Res
1 Kardiol Pol
1 Neonatology
1 Pediatr Crit Care Med
1 Sci Rep
1 Zhonghua Yi Xue Za Zhi

  Retrieve available abstracts of this week’s articles:
HTML format
Text format
Single Articles

    A A Pract

  1. ICHIYANAGI S, Takeshita I, Kandil AI, Miyazu M, et al
    Pulmonary Hypertensive Crisis During General Anesthesia in a 3-Year-Old Autistic Boy With Undiagnosed Scurvy, Undergoing Cardiac Catheterization: A Case Report.
    A A Pract. 2019 Sep 16. doi: 10.1213/XAA.0000000000001087.
    PubMed     Text format     Abstract available

    Am J Physiol Lung Cell Mol Physiol

  2. JALCE G, Guignabert C
    The Multiple Roles of Macrophage Migration Inhibitory Factor in Pulmonary Hypertension.
    Am J Physiol Lung Cell Mol Physiol. 2019 Oct 2. doi: 10.1152/ajplung.00234.2019.
    PubMed     Text format     Abstract available


  3. MILLER RJH, Banerjee D
    Pulmonary Hypertension Is a Potentially Reversible Contraindication to Cardiac Transplantation.
    ASAIO J. 2019 Sep 18. doi: 10.1097/MAT.0000000000001070.
    PubMed     Text format    


  4. ANDERSON JJ, Lau EM, Lavender M, Benza R, et al
    Retrospective validation of the REVEAL 2.0 Risk Score with the Australian and New Zealand Pulmonary Hypertension Registry Cohort.
    Chest. 2019 Sep 26. pii: S0012-3692(19)33934.
    PubMed     Text format     Abstract available

    Chin J Physiol

  5. CHANG Z, Zhang P, Zhang M, Jun F, et al
    Aloperine suppresses human pulmonary vascular smooth muscle cell proliferation via inhibiting inflammatory response.
    Chin J Physiol. 2019;62:157-165.
    PubMed     Text format     Abstract available


  6. CHEN KH, Dasgupta A, Lin J, Potus F, et al
    Epigenetic Dysregulation of the Drp1 Binding Partners MiD49 and MiD51 Increases Mitotic Mitochondrial Fission and Promotes Pulmonary Arterial Hypertension: Mechanistic and Therapeutic Implications.
    Circulation. 2018 Feb 5. pii: CIRCULATIONAHA.117.031258.
    PubMed     Text format     Abstract available

  7. RUOPP NF, Farber HW
    The New World Symposium on Pulmonary Hypertension Guidelines: Should Twenty-One Be the New Twenty-Five?
    Circulation. 2019;140:1134-1136.
    PubMed     Text format    

    Clin Respir J

  8. LIU M, Yuan Q, Zhao H, Wang Y, et al
    Williams-Campbell syndrome complicated with pulmonary hypertension and Type 2 respiratory failure: A adult case Report.
    Clin Respir J. 2019 Sep 27. doi: 10.1111/crj.13090.
    PubMed     Text format     Abstract available

    Cochrane Database Syst Rev

  9. SHIVANNA B, Gowda S, Welty SE, Barrington KJ, et al
    Prostanoids and their analogues for the treatment of pulmonary hypertension in neonates.
    Cochrane Database Syst Rev. 2019;10:CD012963.
    PubMed     Text format     Abstract available

    Eur Heart J

  10. WEATHERALD J, Sitbon O, Humbert M
    Validation of a risk assessment instrument for pulmonary arterial hypertension.
    Eur Heart J. 2017 Jun 13. doi: 10.1093.
    PubMed     Text format    

    Eur J Pharmacol

  11. LIU H, Ge XY, Huang N, Liu T, et al
    Up-regulation of cullin7 promotes proliferation and migration of pulmonary artery smooth muscle cells in hypoxia-induced pulmonary hypertension.
    Eur J Pharmacol. 2019 Sep 26:172698. doi: 10.1016/j.ejphar.2019.172698.
    PubMed     Text format     Abstract available

    Int J Chron Obstruct Pulmon Dis

  12. COSTE F, Benlala I, Dournes G, Girodet PO, et al
    Assessing pulmonary hypertension in COPD. Is there a role for computed tomography?
    Int J Chron Obstruct Pulmon Dis. 2019;14:2065-2079.
    PubMed     Text format     Abstract available

    J Appl Physiol (1985)

  13. FAN C, Wang J, Mao C, Li W, et al
    The Fgl2 prothrombinase contributes to the pathological process of experimental pulmonary hypertension.
    J Appl Physiol (1985). 2019 Oct 3. doi: 10.1152/japplphysiol.00396.2019.
    PubMed     Text format     Abstract available

    J Cardiovasc Thorac Res

  14. LIAO S, Li D, Hui Z, McLachlan CS, et al
    Chronic dosing with metformin plus bosentan decreases in vitro pulmonary artery contraction from isolated arteries in adults with pulmonary hypertension.
    J Cardiovasc Thorac Res. 2019;11:189-195.
    PubMed     Text format     Abstract available

    Kardiol Pol

  15. SLAWEK-SZMYT S, Araszkiewicz A, Janus M, Jankiewicz S, et al
    Under pressure closure of atrial septal defect type II in a patient with pulmonary hypertension.
    Kardiol Pol. 2019 Oct 1. doi: 10.33963/KP.15004.
    PubMed     Text format    


  16. JIMENEZ J, Lesage F, Richter J, Nagatomo T, et al
    Upregulation of Vascular Endothelial Growth Factor in Amniotic Fluid Stem Cells Enhances Their Potential to Attenuate Lung Injury in a Preterm Rabbit Model of Bronchopulmonary Dysplasia.
    Neonatology. 2018;113:275-285.
    PubMed     Text format     Abstract available

    Pediatr Crit Care Med

  17. MORELL E, Rajagopal SK, Oishi P, Thiagarajan RR, et al
    Extracorporeal Membrane Oxygenation in Pediatric Pulmonary Hypertension.
    Pediatr Crit Care Med. 2019 Oct 2. doi: 10.1097/PCC.0000000000002127.
    PubMed     Text format     Abstract available

    Sci Rep

  18. ZAW AM, Sekar R, Mak SOK, Law HKW, et al
    Loss of secretin results in systemic and pulmonary hypertension with cardiopulmonary pathologies in mice.
    Sci Rep. 2019;9:14211.
    PubMed     Text format     Abstract available

    Zhonghua Yi Xue Za Zhi

  19. YANG SQ, Yang YH, Kuang TG, Liu L, et al
    [Analysis of clinical features and targeted drug therapy of portopulmonary hypertension].
    Zhonghua Yi Xue Za Zhi. 2019;99:2806-2810.
    PubMed     Text format     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Pulmonary Hypertension is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.